Today's Date
Type 1 Diabetes Immunotherapy Using Polyclonal Tregs
(
JDRF Treg
)
ITN Protocol #:
ITN819AI
Branded Name:
JDRF Treg
Treatment Protocol #:
T Reg
Therapeutic Area:
Type 1 Diabetes
Current Status:
Complete
Summary:
A Phase I Safety Trial of CD4+CD127lo/-CD25+ Polyclonal Treg Adoptive Immunotherapy for the Treatment of Type 1 Diabetes
Clinical Operations Manager
ITN Biostat
ITN Clinical Trial Physician
Study Personnel:
